The Importance of Reverse Translation for Preclinical Off-Target Mitigation: Quantification and Mitigation of Biases in the FDA Adverse Event Reporting System

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Chemistry

Medicine

Immunology

Show all topics

DOI

10.1101/068692

License

CC-BY-ND

Other Formats

PDF